Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet

Osteoarthritis and Cartilage

Volumn 21, Issue 2, 2013, Pages 322-330

  Triantaphyllidou, I E ^a,b   Kalyvioti, E ^a   Karavia, E ^a   Lilis, I ^a   Kypreos, K E ^a   Papachristou, D J ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I; High density lipoprotein; Lecithin cholesterol acyltransferase; Obesity; Osteoarthritis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW; CONTROLLED STUDY; DIETARY INTAKE; LONG TERM CARE; MALE; METABOLIC SYNDROME X; METABOLISM; MOUSE; MOUSE STRAIN; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; APOLIPOPROTEIN A-I; BODY WEIGHT; CAUSALITY; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; LECITHIN ACYLTRANSFERASE DEFICIENCY; LIPIDS; LIPOPROTEINS, HDL; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; OSTEOARTHRITIS, KNEE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; TIME FACTORS; WESTERN WORLD;

EID: 84872668800     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.11.003     Document Type: Article

References (39)

1. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 2004, 12(Suppl A):S31-S33.
2. Aspden R.M. Obesity punches above its weight in osteoarthritis. Nat Rev Rheumatol 2011, 7:65-68.
3. Carman W.J., Sowers M., Hawthorne V.M., Weissfeld L.A. Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am J Epidemiol 1994, 139:119-129.
4. Dahaghin S., Bierma-Zeinstra S.M., Koes B.W., Hazes J.M., Pols H.A. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam study. Ann Rheum Dis 2007, 66:916-920.
5. Dahaghin S., Bierma-Zeinstra S.M., Reijman M., Pols H.A., Hazes J.M., Koes B.W. Does hand osteoarthritis predict future hip or knee osteoarthritis?. Arthritis Rheum 2005, 52:3520-3527.
6. Velasquez M.T., Katz J.D. Osteoarthritis: another component of metabolic syndrome?. Metab Syndr Relat Disord 2010, 8:295-305.
7. Karvonen-Gitierrez C.A., Sowers M.F.R., Heeringa S.G. Sex dimorphism in the association of cardiometabolic characteristics and osteophytes-defined radiographic knee osteoarthritis among obese and non-obese adults: NHANES III. Osteoarthritis Cartilage 2012, 20:614-621.
8. Soran N., Altindag O., Cakir H., Celik H., Demirkol A., Aksoy N. Assessment of paraoxonase activities in patients with knee osteoarthritis. Redox Rep 2008, 13:194-198.
9. Osuga T., Portman O.W. Origin and disappearance of plasma lecithin: cholesterol acyltransferase. Am J Physiol 1971, 220:735-741.
10. Fielding C.J., Shore V.G., Fielding P.E. A protein cofactor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 1972, 46(4):1493-1498.
11. Kypreos K.E., Zannis V.I. Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochem J 2007, 403:359-367.
12. Karavia E.A., Papachristou D.J., Liopeta K., Triantafyllidou I.E., Dimitrakopoulos O., Kypreos K.E. Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice. Mol Med 2012, 18:901-912.
13. Karavia E.A., Papachristou D.J., Kotsikogianni I., Triantafyllidou I.E., Kypreos K.E. Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice. J Nutr Biochem 2012, [e-Pub ahead of print].
14. Sakai N., Vaisman B.L., Koch C.A., Hoyt R.F., Meyn S.M., Talley G.D., et al. Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency. J Biol Chem 1997, 272:7506-7510.
15. Kypreos K.E. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia. Biochemistry 2008, 47:10491-10502.
16. Karagiannides I., Abdou R., Tzortzopoulou A., Voshol P.J., Kypreos K.E. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS J 2008, 275:4796-4809.
17. Duivenvoorden I., Teusink B., Rensen P.C., Romijn J.A., Havekes L.M., Voshol P.J. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. Diabetes 2005, 54:664-671.
18. Glasson S.S., Chambers M.G., Van Den Berg W.B., Little C.B. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010, 18(Suppl 3):S17-S23.
19. Skandalis S.S., Theocharis D.A., Papageorgakopoulou N., Vynios D.H. The extractability of extracellular matrix components as a marker of cartilage remodeling in laryngeal squamous cell carcinoma. Biochim Biophys Acta 2005, 1721:81-88.
20. Syggelos S.A., Giannopoulou E., Gouvousis P.A., Andonopoulos A.P., Aletras A.J., Panagiotopoulos E. In vitro effects of non-steroidal anti-inflammatory drugs on cytokine, prostanoid and matrix metalloproteinase production by interface membranes from loose hip or knee endoprostheses. Osteoarthritis Cartilage 2007, 15:531-542.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Hart D.J., Doyle D.V., Spector T.D. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995, 22:1118-1123.
23. Aspden R.M. Osteoarthritis: a problem of growth not decay?. Rheumatology (Oxford) 2008, 47:1452-1460.
24. Gkretsi V., Simopoulou T., Tsezou A. Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res 2011, 50:133-140.
25. Dumond H., Presle N., Terlain B., Mainard D., Loeuille D., Netter P., et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003, 48:3118-3129.
26. Iliopoulos D., Malizos K.N., Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007, 66:1616-1621.
27. Griffin T.M., Huebner J.L., Kraus V.B., Guilak F. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum 2009, 60:2935-2944.
28. Gegout P.P., Francin P.J., Mainard D., Presle N. Adipokines in osteoarthritis: friends or foes of cartilage homeostasis?. Joint Bone Spine 2008, 75:669-671.
29. Hu P.F., Bao J.P., Wu L.D. The emerging role of adipokines in osteoarthritis: a narrative review. Mol Biol Rep 2011, 38:873-878.
30. Griffin T.M., Fermor B., Huebner J.L., Kraus V.B., Rodriguiz R.M., Wetsel W.C., et al. Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther 2010, 12:R130.
31. Tsompanidi E.M., Brinkmeier M.S., Fotiadou E.H., Giakoumi S.M., Kypreos K.E. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 2009, 208:3-9.
32. Kypreos K.E. HDL quality in atherosclerosis: can ratios between apolipoproteins of HDL be used effectively to indicate risk of premature myocardial infarction?. Clin Lipidol 2012, 7:127-129.
33. Collins-Racie L.A., Yang Z., Arai M., Li N., Majumdar M.K., Nagpal S., et al. Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis. Osteoarthritis Cartilage 2009, 17:832-842.
34. Gierman L.M., van der Ham F., Koudijs A., Wielinga P.Y., Kleemann R., Kooistra T., et al. Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice. Arthritis Rheum 2012, 64:1172-1181.
35. Mooney R.A., Sampson E.R., Lerea J., Rosier R.N., Zuscik M.J. High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury. Arthritis Res Ther 2011, 13(6):R198.
36. Tsezou A., Iliopoulos D., Malizos K.N., Simopoulou T. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J Orthop Res 2010, 28:1033-1039.
37. Lazarenko O.P., Rzonca S.O., Hogue W.R., Swain F.L., Suva L.J., Lecka-Czernik B. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone. Endocrinology 2007, 148:2669-2680.
38. Plumb M.S., Aspden R.M. High levels of fat (n-6) fatty acids in cancellous bone in osteoarthritis. Lipids Health Dis 2004, 3:12.
39. Lecka-Czernik B. Marrow fat metabolism is linked to the systemic energy metabolism. Bone 2012, 50:534-539.